Key Record Dates
ClinicalTrials.gov Identifier: | NCT03802396 |
---|---|
Brief Title: | Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction (MARBLE) |
First Submitted : | January 10, 2019 |
First Submitted that Met QC Criteria : | January 10, 2019 |
First Posted : | January 14, 2019 |
Last Update Submitted that Met QC Criteria : | July 10, 2020 |
Last Update Posted : | July 14, 2020 |